
| Company | Weightage (%) |
| Sun Pharmaceutical Industries Ltd. | 13.20% |
| Divis Laboratories Ltd. | 6.00% |
| Cipla Ltd. | 5.90% |
| Dr Reddys Laboratories Ltd. | 5.80% |
| Apollo Hospitals Enterprise Ltd. | 5.60% |
| Max Healthcare Institute Ltd. | 5.50% |
| Lupin Ltd. | 4.10% |
| Fortis Healthcare Ltd. | 3.50% |
| Torrent Pharmaceuticals Ltd. | 3.20% |
| Laurus Labs Ltd. | 2.90% |
The current market price of Motilal Oswal S&P BSE Healthcare ETF is ₹48.59. ETF prices fluctuate during market hours based on demand, supply, and movements in the underlying index or assets.
Motilal Oswal S&P BSE Healthcare ETF by Motilal Oswal Asset Management Company Limited targets returns mirroring the BSE Healthcare TRI before expenses, operates as a sector-specific ETF focusing on healthcare. The fund seeks passive replication against the BSE Healthcare Total Return Index, implementing a tracking approach replicating index constituents and seeking to deliver returns aligned with the benchmark's total return. Portfolio concentrates in pharmaceuticals and biotechnology, with Sun Pharmaceutical Industries Ltd. at 13.2%, Divis 6.0% and Cipla 5.9%, cumulatively reflecting sector concentration of 75.6% and notable single-stock weights notably present. Performance shows 1Y: +2.3% and 3Y CAGR: +24.8%, a sharp divergence that highlights episodic returns and suggests higher short-term variability contrasting with strong multi-year compounding within the sector during cycles. Operationally the ETF has expense ratio 0.2% with AUM ₹40.2 Cr (Jan 2026) and monthly average ₹39.5 Cr; managers Swapnil Mayekar Jul 2022 (20y) and Dishant Mehta Oct 2024 (14y).
Motilal Oswal S&P BSE Healthcare ETF is designed to track BSE Healthcare Total Return Index, allowing investors to gain exposure to its underlying securities through a single investment.
The expense ratio of Motilal Oswal S&P BSE Healthcare ETF is 0.23%. This represents the annual fee charged by the fund house for managing the ETF and is deducted from the fund’s assets.
The Assets Under Management (AUM) of Motilal Oswal S&P BSE Healthcare ETF is approximately ₹40.21. AUM reflects the total market value of assets managed by the ETF and is often used as an indicator of fund size and liquidity.
Motilal Oswal S&P BSE Healthcare ETF is classified under the as per the risk-o-meter defined by the fund house risk category. The risk level depends on the volatility of the underlying index, market conditions, and asset composition of the ETF.
The tracking error of Motilal Oswal S&P BSE Healthcare ETF is depends on how closely the ETF follows its benchmark. Tracking error measures how closely the ETF’s performance matches its benchmark index over time.
Motilal Oswal S&P BSE Healthcare ETF does not currently declare dividends and may reinvest earnings into the fund. Dividend treatment depends on the ETF structure and fund house policy.
Based on available data, Motilal Oswal S&P BSE Healthcare ETF has delivered the following returns: 1-year return: 12.28%. 3-year return: 106.99%. 5-year return: 107.97%. Past performance does not guarantee future results.
Before investing in Motilal Oswal S&P BSE Healthcare ETF, investors generally consider the underlying index, expense ratio, tracking error, risk profile, liquidity, and how the ETF fits within their overall portfolio strategy.
40
0.23%
—
—
Low Risk
0.13
—
40.75
48.45
0.839
—
Bullish
78.18
45.20
44.62
Allocation
52.20
▲ 0.06%
62.80
▲ 1.05%
63.29
▼ 0.02%
131.08
▼ 0.09%
48.59
▲ 1.23%
106.01
▲ 0.82%
60.65
▼ 0.28%
325.74
▼ 0.41%
52.06
▼ 0.88%
56.20
▲ 0.12%
116.00
▲ 0.43%
247.14
▼ 0.18%
16.83
▲ 0.60%
24.70
▼ 0.08%
31.82
▲ 0.00%
32.72
▲ 0.37%
77.56
▲ 1.06%
29.68
▼ 0.84%
72.47
▲ 0.46%
36.38
▲ 0.11%
201.88
▲ 0.65%
40.55
▲ 0.52%
157.41
▲ 0.61%
100.15
▲ 1.19%
63.51
▲ 0.05%
155.81
▲ 0.04%
259.59
▼ 0.66%
69.46
▲ 0.32%
23.11
▲ 0.65%
43.06
▼ 0.32%
66.00
▲ 0.08%

AUM
₹ 40 Cr
Expense Ratio
0.23%
Performance
STEADY PERFORMER
Technicals
Bullish
Risk
—
Liquidity
NEUTRAL
Consistency
GOOD
Bearish
5
Neutral
4
Bullish
5
Bearish
5
Neutral
4
Bullish
37
Bearish
0
Neutral
0
Bullish
32